Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy
- 1 October 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 141 (11), 1424-1427
- https://doi.org/10.1001/archinte.141.11.1424
Abstract
• Metronidazole has important in vitro bactericidal activity against strict anaerobic bacteria and has been used successfully in the treatment of infection due to these organisms. In this randomized study, the efficacy of metronidazole was compared with clindamycin in the treatment of patients with anaerobic lung abscess or necrotizing pneumonia. Six patients with lung abscesses and one with necrotizing pneumonia received metronidazole; six patients with lung abscesses, three with necrotizing pneumonia, and one with pneumonia and empyema received clindamycin. Three patients with lung abscesses and one with necrotizing pneumonia failed to respond to metronidazole treatment. One clindamycin-treated patient died of causes unrelated to antibiotic therapy. The results of this study suggest that metronidazole treatment of anaerobic pulmonary infections is less effective than currently available therapy. (Arch Intern Med 1981;141:1424-1427)This publication has 2 references indexed in Scilit:
- Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscessArchives of Internal Medicine, 1979
- A new approach to patients with suspected anaerobic postpartum pelvic infections. Transabdominal uterine aspiration for culture and metronidazole for treatmentAmerican Journal of Obstetrics and Gynecology, 1976